Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06224218
NA

Prostate Single Port & Laser Enucleation Comparison Trial

Sponsor: University of Illinois at Chicago

View on ClinicalTrials.gov

Summary

Surgical treatments for benign prostatic hyperplasia (BPH) are necessary when non-procedural approaches fail to alleviate lower urinary tract symptoms (LUTS) or bladder outlet obstruction (BOO). Open simple prostatectomy and laser enucleation are recommended for prostatic adenoma size greater than 80 ml. Minimally invasive approaches, such as robotic-assisted simple prostatectomy, have gained popularity due to their comparable outcomes with lower morbidity. The introduction of the da Vinci single-port (SP) robotic platform offers potential advantages, but its outcomes have not been thoroughly investigated. This randomized controlled trial aims to compare the outcomes of SP simple prostatectomy performed using the da Vinci robotic platform versus thulium laser enucleation of the prostate for the treatment of BPH and BOO.

Official title: Randomized Controlled Trial Comparing Single Port Simple Prostatectomy and Laser Enucleation of the Prostate for Benign Prostatic Hyperplasia

Key Details

Gender

MALE

Age Range

18 Years - 88 Years

Study Type

INTERVENTIONAL

Enrollment

116

Start Date

2024-01-15

Completion Date

2027-08-15

Last Updated

2024-05-16

Healthy Volunteers

No

Interventions

PROCEDURE

Single Port Robotic Surgery

Single port Robotic surgery will remove the whole prostate

PROCEDURE

Laser Surgery

Laser enucleation will remove chips of the prostate but keeping intact the prostate capsule.

Locations (1)

UI Health SCB Clinic Department of Urology

Chicago, Illinois, United States